A glucagon receptor agonist is a compound that binds to and activates the glucagon receptor, stimulating liver glucose production, lipid breakdown (lipolysis), and energy expenditure.
While pure glucagon raises blood sugar, modern multi-receptor drugs combine glucagon activity with GLP-1 and GIP agonists to drive significant weight loss.
It stimulates the glucagon receptor to help increase the body’s calorie-burning rate.
Promotes the breakdown of stored fats and liver glycogen.
Appetite Control: When paired with GLP-1 and GIP components, it helps reduce food intake and slow digestion.
Retatrutide: A single-molecule “triple-agonist” targeting the GLP-1, GIP, and glucagon receptors, for obesity and liver disease.
Dual Agonists: co-formulations blend glucagon and GLP-1 receptor activation to balance blood sugar with enhanced fat loss.